z-logo
open-access-imgOpen Access
Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
Author(s) -
Shouvik Choudhury,
Moumita Bala,
Debasis Chakraborty,
Sandeep Lahiry
Publication year - 2021
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_93_20
Subject(s) - medicine , pneumonia , community acquired pneumonia , intensive care medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here